Novel variants of the ATRX gene identified in MYCN non-amplified Neuroblastoma in Brazilian patients

This publication has 26 references indexed in Scilit:

• Identification of MYCN non-amplified neuroblastoma subgroups points towards molecular signatures for precision prognosis and therapy stratification
  British Journal of Cancer, 2024
• Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastoma
  EBioMedicine, 2020
• MYCN amplification and ATRX mutations are incompatible in neuroblastoma
  Nature Communications, 2020
• Clinical significance of MYCN amplification in patients with high‐risk neuroblastoma
  Pediatric Blood & Cancer, 2018
• Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries
  Nature Genetics, 2017
• Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT
  Acta Neuropathologica, 2017
• Neuroblastoma
  Nature Reviews Disease Primers, 2016
• Association of Age at Diagnosis and Genetic Mutations in Patients With Neuroblastoma
  JAMA, 2012
• Functional significance of mutations in the Snf2 domain of ATRX
  Human Molecular Genetics, 2011
• Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation
  Proceedings of the National Academy of Sciences, 2007